| Mrs Kristin Sears-kopp, MA, CCC-SLP | |
|
2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462-1047 | |
| (800) 879-4471 | |
| Not Available |
| Full Name | Mrs Kristin Sears-kopp |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2250 Hickory Rd, Plymouth Meeting, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063630879 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SL007646 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kristin Sears-kopp, MA, CCC-SLP 400 Ripka St, Philadelphia, PA 19128-3335 Ph: (215) 280-9734 | Mrs Kristin Sears-kopp, MA, CCC-SLP 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462-1047 Ph: (800) 879-4471 |
News Archive
An article published in the May 2010 edition of Postgraduate Medicine documents a case study where a previously healthy, 15-week-old male infant was misdiagnosed and died of meningococcal disease. Initially the patient showed signs of the common cold and was treated as such, but symptoms worsened and he was admitted to the hospital emergency department.
Over the past few years, scientists have discovered that a new class of genetic regulators called "microRNAs" influences normal human growth and development. Now, researchers have found that microRNAs also play an important role in human cancer. The findings are published in tomorrow's issue of the journal Nature (June 9).
Pharmos Corporation announced that it has successfully completed a proof-of-concept clinical trial using its compound levotofisopam (S-tofisopam) to treat patients with hyperuricemia and gout.
Patients with acute coronary syndrome who were treated with the experimental drug varespladib were more likely to experience additional cardiovascular events - including sudden death, heart attack and stroke - than those treated with placebo, according to research from the Cleveland Clinic Coordinating Center for Clinical Research (C5Research).
To fully understand brain function and dysfunction, it is important to be able to visualize changes in anatomy and activity in the whole brain.
› Verified 7 days ago
Meredith B. Horne, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd Ste 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 | |
Cherie Levy Roche, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462 Phone: 800-879-4471 | |
Burnetta Swartz, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Ste 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 | |
Ms. Vicki Lynn Meitus, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 502 W Germantown Pike, Suite 200, Plymouth Meeting, PA 19462 Phone: 610-825-9360 | |
Ann Elizabeth Bollenbach, MED CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Road, Suite 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 Fax: 610-834-7525 | |
Mrs. Mila Marie Capuano, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Plymouth Meeting, PA 19462 Phone: 610-834-1122 |